Atlas Trials

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Clinical trial NCT06735508 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06735508
Sponsor
Guangdong Provincial People's Hospital
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
NSCLC
Start date
2025-01-01
Primary completion
2026-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.